# Phase I/II Study of FR104 First Administration In Patient With Renal Transplantation: FIRsT Study

> **NCT04837092** · PHASE1,PHASE2 · COMPLETED · sponsor: **Nantes University Hospital** · enrollment: 10 (actual)

## Conditions studied

- Kidney Transplantation

## Interventions

- **DRUG:** FR104

## Key facts

- **NCT ID:** NCT04837092
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-28
- **Primary completion:** 2025-04-14
- **Final completion:** 2025-04-14
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2026-01-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04837092

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04837092, "Phase I/II Study of FR104 First Administration In Patient With Renal Transplantation: FIRsT Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04837092. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*